Prof. Dr. Markus Neurath

Lehrstuhl für Innere Medizin I (Medizin 1)

Predicting Therapeutic Response by in vivo Molecular Imaging in Inflammatory Bowel Diseases (2016) Atreya R, Neurath M Journal article Serum Autotaxin is a Marker of the Severity of Liver Injury and Overall Survival in Patients with Cholestatic Liver Diseases (2016) Wunsch E, Krawczyk M, Milkiewicz M, Trottier J, Barbier O, Neurath M, Lammert F, et al. Journal article PGAM5-mediated programmed necrosis of hepatocytes drives acute liver injury (2016) He GW, Günther C, Kremer A, Thonn V, Amann KU, Poremba C, Neurath M, et al. Journal article How will new and future therapies change our treatment of IBD? (2016) Zundler S, Neurath M Journal article, Editorial IL-36R signalling activates intestinal epithelial cells and fibroblasts and promotes mucosal healing in vivo (2016) Scheibe K, Backert I, Wirtz S, Hueber A, Schett G, Vieth M, Probst HC, et al. Journal article From bench to bedside: molecular imaging in inflammatory bowel diseases (2016) Atreya R, Neurath M Journal article IRAK-M Expression in Tumor Cells Supports Colorectal Cancer Progression through Reduction of Antimicrobial Defense and Stabilization of STAT3 (2016) Kesselring R, Glaesner J, Hiergeist A, Naschberger E, Neumann H, Brunner SM, Wege AK, et al. Journal article Novel therapeutic approaches in inflammatory bowel diseases (2016) Atreya R, Neurath M Journal article Advances in hepatitis C therapy: What is the current state - what come's next? (2016) Zopf S, Kremer A, Neurath M, Siebler J Journal article Current concepts in chronic inflammatory diseases: Interactions between microbes, cellular metabolism, and inflammation (2016) Garn H, Bahn S, Baune BT, Binder EB, Bisgaard H, Chatila TA, Chavakis T, et al. Journal article